Proper dosing is needed to achieve optimal blood sugar control and minimize the risk of side effects
(2003), which tested BPC-157 on transected rat Achilles tendons
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Mice fed with corn peptides alongside an HFD mitigated weight gain and adverse effects on the liver
Recently, new UV filters have been developed to enable a more complete coverage of the full UV spectrum, such as bis-(diethylaminohydroxybenzoyl) benzoyl piperazine (BDBP) [45], phenylene bis-diphenyltriazine [46], or the UVA1 filter methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (MCE) with a peak of absorption at 385 nm [47] shown to significantly improve photoprotection against UV-induced hyperpigmentation [48, 49]
